DOK6 and acute promyelocytic leukemia: Furthermore, among non‐APL patients, the patients with DOK6 promoter methylation also had significantly longer OS than those without DOK6 promoter methylation (mean 19.17 vs 9.96 months; P = .036; Figure 3B).